Listing 1 - 9 of 9 |
Sort by
|
Choose an application
A virus is considered a nanoscale organic material that can infect and replicate only inside the living cells of other organisms, ranging from animals and plants to microorganisms, including bacteria and archaea. The structure of viruses consists of two main parts: the genetic material from either DNA or RNA that carries genetic information, and a protein coat, called the capsid, which surrounds and protects the genetic material. By inserting the gene encoding functional proteins into the viral genome, the functional proteins can be genetically displayed on the protein coat to form bioengineered viruses. Therefore, viruses can be considered biological nanoparticles with genetically tunable surface chemistry and can serve as models for developing virus-like nanoparticles and even nanostructures. Via this process of viral display, bioengineered viruses can be mass-produced with lower cost and potentially used for energy and biomedical applications. This book highlights the recent developments and future directions of virus-based nanomaterials and nanostructures. The virus-based biomimetic materials formulated using innovative ideas were characterized for the applications of biosensors and nanocarriers. The research contributions and trends on virus-based materials covering energy harvesting devices to tissue regeneration in the last two decades are discussed.
virus-like particles --- glioblastoma --- convection-enhanced delivery --- tobacco mosaic virus --- bioconjugation --- doxorubicin --- drug delivery --- protein-based nanomaterials --- viral capsid --- VLPs --- hepatitis B virus capsid protein --- HBc --- viral self-assembly --- magnetic core --- HBcAg --- BmNPV bacmid --- nanobiomaterials --- Neospora caninum --- Neospora caninum profilin --- neosporosis --- silkworm expression system --- ZnS --- bio/inorganic hybrid materials --- hydrophobization --- polymer coupling --- virus --- tissue regeneration --- biomimetic nanocomposites --- phage display --- nano-vaccines --- HIV-1 Env trimers --- B-cell targeting --- intrastructural help --- VNPs --- Hsp60 --- IBD --- autoantibody --- inflammation --- diagnosis --- biosensor --- M13 bacteriophage --- color sensor --- energy generator --- piezoelectric --- self-assembly --- genetic engineering --- multi-array sensors --- hierarchical cluster analysis --- high selectivity --- piezoelectric materials --- organic materials --- biomaterials --- energy applications --- biomedical applications --- virus-based nanomaterials --- energy devices --- piezoelectric biomaterials
Choose an application
The structure, uniformity, stability, and functions of virus-like particles (VLPs) have encouraged scientists to utilize them as a unique tool in various applications in biomedical fields. Their interaction with the innate immune system is of major importance for the adaptive immune response they induce. The innate immune cells and molecules recognize and interact with VLPs on the basis of two major characteristics: size and surface geometry. VLP-based vaccines against hepatitis B, human papilloma, malaria, and hepatitis E have been developed and are available in many countries around the world. Given the inherent immunogenicity of VLPs, they render themselves ideal for the development of new vaccines against infectious diseases as well as noncommunicable diseases, such as chronic inflammation or cancer. This Special Issue is designed to provide an up-to-date view of the latest progress in the development of VLP-based prophylactic and therapeutic vaccines and technologies for their generation.
Humanities --- Social interaction --- virus-like particle --- influenza A(H1N1)pdm09 --- vaccination --- pregnant women --- antibody titers --- norovirus --- VLP --- vaccine --- genotype --- pre-existing immunity --- cross-reactivity --- blocking antibodies --- original antigenic sin (OAS) --- HPVs --- vaccines --- virus-like particles (VLPs) --- minor capsid protein (L2) --- HCMV --- cytomegalovirus --- nanoparticle --- immune response --- Sudan virus --- mice --- horse --- purified IgG --- long-lived plasma cells --- antibodies --- multivalency --- virus-like particles --- antigenic analysis --- epitope characterization --- hepatitis E vaccine --- serological evaluation --- virion-like epitopes --- well-characterized vaccines --- hepatitis B virus --- surface (envelope) antigen --- sub-viral particle --- capsid --- antigen display --- platform --- viral quantification --- NTA --- flow virometry --- SRFM --- cryo-TEM --- SEM --- plant virus --- virus-like --- vaccine platform --- epitope --- antigen --- cat allergy --- Fel d 1 --- HypoCat™ --- IL-13 --- interleukin-13 --- Tfh cells --- cancer --- immunotherapy --- H7N9 --- pandemic influenza A --- avian flu --- IAV --- VLP vaccine --- virus-like particle --- influenza A(H1N1)pdm09 --- vaccination --- pregnant women --- antibody titers --- norovirus --- VLP --- vaccine --- genotype --- pre-existing immunity --- cross-reactivity --- blocking antibodies --- original antigenic sin (OAS) --- HPVs --- vaccines --- virus-like particles (VLPs) --- minor capsid protein (L2) --- HCMV --- cytomegalovirus --- nanoparticle --- immune response --- Sudan virus --- mice --- horse --- purified IgG --- long-lived plasma cells --- antibodies --- multivalency --- virus-like particles --- antigenic analysis --- epitope characterization --- hepatitis E vaccine --- serological evaluation --- virion-like epitopes --- well-characterized vaccines --- hepatitis B virus --- surface (envelope) antigen --- sub-viral particle --- capsid --- antigen display --- platform --- viral quantification --- NTA --- flow virometry --- SRFM --- cryo-TEM --- SEM --- plant virus --- virus-like --- vaccine platform --- epitope --- antigen --- cat allergy --- Fel d 1 --- HypoCat™ --- IL-13 --- interleukin-13 --- Tfh cells --- cancer --- immunotherapy --- H7N9 --- pandemic influenza A --- avian flu --- IAV --- VLP vaccine
Choose an application
A virus is considered a nanoscale organic material that can infect and replicate only inside the living cells of other organisms, ranging from animals and plants to microorganisms, including bacteria and archaea. The structure of viruses consists of two main parts: the genetic material from either DNA or RNA that carries genetic information, and a protein coat, called the capsid, which surrounds and protects the genetic material. By inserting the gene encoding functional proteins into the viral genome, the functional proteins can be genetically displayed on the protein coat to form bioengineered viruses. Therefore, viruses can be considered biological nanoparticles with genetically tunable surface chemistry and can serve as models for developing virus-like nanoparticles and even nanostructures. Via this process of viral display, bioengineered viruses can be mass-produced with lower cost and potentially used for energy and biomedical applications. This book highlights the recent developments and future directions of virus-based nanomaterials and nanostructures. The virus-based biomimetic materials formulated using innovative ideas were characterized for the applications of biosensors and nanocarriers. The research contributions and trends on virus-based materials covering energy harvesting devices to tissue regeneration in the last two decades are discussed.
History of engineering & technology --- virus-like particles --- glioblastoma --- convection-enhanced delivery --- tobacco mosaic virus --- bioconjugation --- doxorubicin --- drug delivery --- protein-based nanomaterials --- viral capsid --- VLPs --- hepatitis B virus capsid protein --- HBc --- viral self-assembly --- magnetic core --- HBcAg --- BmNPV bacmid --- nanobiomaterials --- Neospora caninum --- Neospora caninum profilin --- neosporosis --- silkworm expression system --- ZnS --- bio/inorganic hybrid materials --- hydrophobization --- polymer coupling --- virus --- tissue regeneration --- biomimetic nanocomposites --- phage display --- nano-vaccines --- HIV-1 Env trimers --- B-cell targeting --- intrastructural help --- VNPs --- Hsp60 --- IBD --- autoantibody --- inflammation --- diagnosis --- biosensor --- M13 bacteriophage --- color sensor --- energy generator --- piezoelectric --- self-assembly --- genetic engineering --- multi-array sensors --- hierarchical cluster analysis --- high selectivity --- piezoelectric materials --- organic materials --- biomaterials --- energy applications --- biomedical applications --- virus-based nanomaterials --- energy devices --- piezoelectric biomaterials --- virus-like particles --- glioblastoma --- convection-enhanced delivery --- tobacco mosaic virus --- bioconjugation --- doxorubicin --- drug delivery --- protein-based nanomaterials --- viral capsid --- VLPs --- hepatitis B virus capsid protein --- HBc --- viral self-assembly --- magnetic core --- HBcAg --- BmNPV bacmid --- nanobiomaterials --- Neospora caninum --- Neospora caninum profilin --- neosporosis --- silkworm expression system --- ZnS --- bio/inorganic hybrid materials --- hydrophobization --- polymer coupling --- virus --- tissue regeneration --- biomimetic nanocomposites --- phage display --- nano-vaccines --- HIV-1 Env trimers --- B-cell targeting --- intrastructural help --- VNPs --- Hsp60 --- IBD --- autoantibody --- inflammation --- diagnosis --- biosensor --- M13 bacteriophage --- color sensor --- energy generator --- piezoelectric --- self-assembly --- genetic engineering --- multi-array sensors --- hierarchical cluster analysis --- high selectivity --- piezoelectric materials --- organic materials --- biomaterials --- energy applications --- biomedical applications --- virus-based nanomaterials --- energy devices --- piezoelectric biomaterials
Choose an application
The structure, uniformity, stability, and functions of virus-like particles (VLPs) have encouraged scientists to utilize them as a unique tool in various applications in biomedical fields. Their interaction with the innate immune system is of major importance for the adaptive immune response they induce. The innate immune cells and molecules recognize and interact with VLPs on the basis of two major characteristics: size and surface geometry. VLP-based vaccines against hepatitis B, human papilloma, malaria, and hepatitis E have been developed and are available in many countries around the world. Given the inherent immunogenicity of VLPs, they render themselves ideal for the development of new vaccines against infectious diseases as well as noncommunicable diseases, such as chronic inflammation or cancer. This Special Issue is designed to provide an up-to-date view of the latest progress in the development of VLP-based prophylactic and therapeutic vaccines and technologies for their generation.
Humanities --- Social interaction --- virus-like particle --- influenza A(H1N1)pdm09 --- vaccination --- pregnant women --- antibody titers --- norovirus --- VLP --- vaccine --- genotype --- pre-existing immunity --- cross-reactivity --- blocking antibodies --- original antigenic sin (OAS) --- HPVs --- vaccines --- virus-like particles (VLPs) --- minor capsid protein (L2) --- HCMV --- cytomegalovirus --- nanoparticle --- immune response --- Sudan virus --- mice --- horse --- purified IgG --- long-lived plasma cells --- antibodies --- multivalency --- virus-like particles --- antigenic analysis --- epitope characterization --- hepatitis E vaccine --- serological evaluation --- virion-like epitopes --- well-characterized vaccines --- hepatitis B virus --- surface (envelope) antigen --- sub-viral particle --- capsid --- antigen display --- platform --- viral quantification --- NTA --- flow virometry --- SRFM --- cryo-TEM --- SEM --- plant virus --- virus-like --- vaccine platform --- epitope --- antigen --- cat allergy --- Fel d 1 --- HypoCat™ --- IL-13 --- interleukin-13 --- Tfh cells --- cancer --- immunotherapy --- H7N9 --- pandemic influenza A --- avian flu --- IAV --- VLP vaccine --- n/a
Choose an application
A virus is considered a nanoscale organic material that can infect and replicate only inside the living cells of other organisms, ranging from animals and plants to microorganisms, including bacteria and archaea. The structure of viruses consists of two main parts: the genetic material from either DNA or RNA that carries genetic information, and a protein coat, called the capsid, which surrounds and protects the genetic material. By inserting the gene encoding functional proteins into the viral genome, the functional proteins can be genetically displayed on the protein coat to form bioengineered viruses. Therefore, viruses can be considered biological nanoparticles with genetically tunable surface chemistry and can serve as models for developing virus-like nanoparticles and even nanostructures. Via this process of viral display, bioengineered viruses can be mass-produced with lower cost and potentially used for energy and biomedical applications. This book highlights the recent developments and future directions of virus-based nanomaterials and nanostructures. The virus-based biomimetic materials formulated using innovative ideas were characterized for the applications of biosensors and nanocarriers. The research contributions and trends on virus-based materials covering energy harvesting devices to tissue regeneration in the last two decades are discussed.
History of engineering & technology --- virus-like particles --- glioblastoma --- convection-enhanced delivery --- tobacco mosaic virus --- bioconjugation --- doxorubicin --- drug delivery --- protein-based nanomaterials --- viral capsid --- VLPs --- hepatitis B virus capsid protein --- HBc --- viral self-assembly --- magnetic core --- HBcAg --- BmNPV bacmid --- nanobiomaterials --- Neospora caninum --- Neospora caninum profilin --- neosporosis --- silkworm expression system --- ZnS --- bio/inorganic hybrid materials --- hydrophobization --- polymer coupling --- virus --- tissue regeneration --- biomimetic nanocomposites --- phage display --- nano-vaccines --- HIV-1 Env trimers --- B-cell targeting --- intrastructural help --- VNPs --- Hsp60 --- IBD --- autoantibody --- inflammation --- diagnosis --- biosensor --- M13 bacteriophage --- color sensor --- energy generator --- piezoelectric --- self-assembly --- genetic engineering --- multi-array sensors --- hierarchical cluster analysis --- high selectivity --- piezoelectric materials --- organic materials --- biomaterials --- energy applications --- biomedical applications --- virus-based nanomaterials --- energy devices --- piezoelectric biomaterials
Choose an application
The structure, uniformity, stability, and functions of virus-like particles (VLPs) have encouraged scientists to utilize them as a unique tool in various applications in biomedical fields. Their interaction with the innate immune system is of major importance for the adaptive immune response they induce. The innate immune cells and molecules recognize and interact with VLPs on the basis of two major characteristics: size and surface geometry. VLP-based vaccines against hepatitis B, human papilloma, malaria, and hepatitis E have been developed and are available in many countries around the world. Given the inherent immunogenicity of VLPs, they render themselves ideal for the development of new vaccines against infectious diseases as well as noncommunicable diseases, such as chronic inflammation or cancer. This Special Issue is designed to provide an up-to-date view of the latest progress in the development of VLP-based prophylactic and therapeutic vaccines and technologies for their generation.
virus-like particle --- influenza A(H1N1)pdm09 --- vaccination --- pregnant women --- antibody titers --- norovirus --- VLP --- vaccine --- genotype --- pre-existing immunity --- cross-reactivity --- blocking antibodies --- original antigenic sin (OAS) --- HPVs --- vaccines --- virus-like particles (VLPs) --- minor capsid protein (L2) --- HCMV --- cytomegalovirus --- nanoparticle --- immune response --- Sudan virus --- mice --- horse --- purified IgG --- long-lived plasma cells --- antibodies --- multivalency --- virus-like particles --- antigenic analysis --- epitope characterization --- hepatitis E vaccine --- serological evaluation --- virion-like epitopes --- well-characterized vaccines --- hepatitis B virus --- surface (envelope) antigen --- sub-viral particle --- capsid --- antigen display --- platform --- viral quantification --- NTA --- flow virometry --- SRFM --- cryo-TEM --- SEM --- plant virus --- virus-like --- vaccine platform --- epitope --- antigen --- cat allergy --- Fel d 1 --- HypoCat™ --- IL-13 --- interleukin-13 --- Tfh cells --- cancer --- immunotherapy --- H7N9 --- pandemic influenza A --- avian flu --- IAV --- VLP vaccine --- n/a
Choose an application
Viruses are microscopic agents that exist worldwide and are present in humans, animals, plants, and other living organisms in which they can cause devastating diseases. However, the advances of biotechnology and next-generation sequencing technologies have accelerated novel virus discovery, identification, sequencing, and manipulation, showing that they present unique characteristics that place them as valuable tools for a wide variety of biotechnological applications. Many applications of viruses have been used for agricultural purposes, namely concerning plant breeding and plant protection. Nevertheless, it is interesting to mention that plants have also many advantages to be used in vaccine production, such as the low cost and low risks they entail, showing once more the versatility of the use of viruses in biotechnology. Although it will obviously never be ignored that viruses are responsible for devastating diseases, it is clear that the more they are studied, the more possibilities they offer to us. They are now on the front line of the most revolutionizing techniques in several fields, providing advances that would not be possible without their existence. In this book there are presented studies that demonstrate the work developed using viruses in biotechnology. These studies were brought by experts that focus on the development and applications of many viruses in several fields, such as agriculture, the pharmaceutical industry, and medicine.
Technology: general issues --- Bacteriophage --- Salmonella --- biocontrol --- comparative genomics --- phage diversity --- grapevine --- apple latent spherical virus vector --- virus-induced flowering --- reduced generation time --- breeding of grapevine --- virus elimination --- Newcastle disease virus --- reverse genetics --- vaccines --- infectious diseases --- cancer --- porcine epidemic diarrhea virus --- VLP --- chemokines --- pig --- vaccine --- SARS-CoV-2 --- COVID-19 --- phages --- CRISPR --- viruses --- prevention --- diagnosis --- treatment --- adeno-associated virus (AAV) vector --- jaagsiekte sheep retrovirus (JSRV) --- LTR --- enhancer --- transduction --- viral vaccines --- cancers --- COVID-19 vaccines --- self-replicating RNA vectors --- DNA-based vaccines --- RNA-based vaccines --- plant virus --- viroid --- viral vector --- virus-induced gene silencing (VIGS) --- CRISPR/Cas9 --- genome editing --- carotenoid biosynthesis --- circular RNA --- infectious bursal disease virus --- immunization --- recombinant Lactococcus lactis --- variant strain --- baculovirus --- insect cells --- bacmid --- Tn7 --- genome stability --- protein expression --- chikungunya virus --- VLPs --- bioreactor --- CRISPR/Cas systems --- viral vectors --- gene editing --- plant genome engineering --- viral resistance --- adeno-associated virus --- AAV --- cancer gene therapy --- prophage --- hydrothermal vent --- Hypnocyclicus thermotrophus --- lytic cassette --- Escherichia coli --- heterologous expression --- codon optimization --- codon harmonization --- expression vectors --- aspect ratio --- VNPs --- TMV --- PVX --- CPMV --- geminivirus --- theranostics --- CRISPR-cas9 --- clodronate --- macrophage --- gene therapy --- gene expression --- nanotechnology --- Bacteriophage --- Salmonella --- biocontrol --- comparative genomics --- phage diversity --- grapevine --- apple latent spherical virus vector --- virus-induced flowering --- reduced generation time --- breeding of grapevine --- virus elimination --- Newcastle disease virus --- reverse genetics --- vaccines --- infectious diseases --- cancer --- porcine epidemic diarrhea virus --- VLP --- chemokines --- pig --- vaccine --- SARS-CoV-2 --- COVID-19 --- phages --- CRISPR --- viruses --- prevention --- diagnosis --- treatment --- adeno-associated virus (AAV) vector --- jaagsiekte sheep retrovirus (JSRV) --- LTR --- enhancer --- transduction --- viral vaccines --- cancers --- COVID-19 vaccines --- self-replicating RNA vectors --- DNA-based vaccines --- RNA-based vaccines --- plant virus --- viroid --- viral vector --- virus-induced gene silencing (VIGS) --- CRISPR/Cas9 --- genome editing --- carotenoid biosynthesis --- circular RNA --- infectious bursal disease virus --- immunization --- recombinant Lactococcus lactis --- variant strain --- baculovirus --- insect cells --- bacmid --- Tn7 --- genome stability --- protein expression --- chikungunya virus --- VLPs --- bioreactor --- CRISPR/Cas systems --- viral vectors --- gene editing --- plant genome engineering --- viral resistance --- adeno-associated virus --- AAV --- cancer gene therapy --- prophage --- hydrothermal vent --- Hypnocyclicus thermotrophus --- lytic cassette --- Escherichia coli --- heterologous expression --- codon optimization --- codon harmonization --- expression vectors --- aspect ratio --- VNPs --- TMV --- PVX --- CPMV --- geminivirus --- theranostics --- CRISPR-cas9 --- clodronate --- macrophage --- gene therapy --- gene expression --- nanotechnology
Choose an application
Viruses are microscopic agents that exist worldwide and are present in humans, animals, plants, and other living organisms in which they can cause devastating diseases. However, the advances of biotechnology and next-generation sequencing technologies have accelerated novel virus discovery, identification, sequencing, and manipulation, showing that they present unique characteristics that place them as valuable tools for a wide variety of biotechnological applications. Many applications of viruses have been used for agricultural purposes, namely concerning plant breeding and plant protection. Nevertheless, it is interesting to mention that plants have also many advantages to be used in vaccine production, such as the low cost and low risks they entail, showing once more the versatility of the use of viruses in biotechnology. Although it will obviously never be ignored that viruses are responsible for devastating diseases, it is clear that the more they are studied, the more possibilities they offer to us. They are now on the front line of the most revolutionizing techniques in several fields, providing advances that would not be possible without their existence. In this book there are presented studies that demonstrate the work developed using viruses in biotechnology. These studies were brought by experts that focus on the development and applications of many viruses in several fields, such as agriculture, the pharmaceutical industry, and medicine.
Technology: general issues --- Bacteriophage --- Salmonella --- biocontrol --- comparative genomics --- phage diversity --- grapevine --- apple latent spherical virus vector --- virus-induced flowering --- reduced generation time --- breeding of grapevine --- virus elimination --- Newcastle disease virus --- reverse genetics --- vaccines --- infectious diseases --- cancer --- porcine epidemic diarrhea virus --- VLP --- chemokines --- pig --- vaccine --- SARS-CoV-2 --- COVID-19 --- phages --- CRISPR --- viruses --- prevention --- diagnosis --- treatment --- adeno-associated virus (AAV) vector --- jaagsiekte sheep retrovirus (JSRV) --- LTR --- enhancer --- transduction --- viral vaccines --- cancers --- COVID-19 vaccines --- self-replicating RNA vectors --- DNA-based vaccines --- RNA-based vaccines --- plant virus --- viroid --- viral vector --- virus-induced gene silencing (VIGS) --- CRISPR/Cas9 --- genome editing --- carotenoid biosynthesis --- circular RNA --- infectious bursal disease virus --- immunization --- recombinant Lactococcus lactis --- variant strain --- baculovirus --- insect cells --- bacmid --- Tn7 --- genome stability --- protein expression --- chikungunya virus --- VLPs --- bioreactor --- CRISPR/Cas systems --- viral vectors --- gene editing --- plant genome engineering --- viral resistance --- adeno-associated virus --- AAV --- cancer gene therapy --- prophage --- hydrothermal vent --- Hypnocyclicus thermotrophus --- lytic cassette --- Escherichia coli --- heterologous expression --- codon optimization --- codon harmonization --- expression vectors --- aspect ratio --- VNPs --- TMV --- PVX --- CPMV --- geminivirus --- theranostics --- CRISPR-cas9 --- clodronate --- macrophage --- gene therapy --- gene expression --- nanotechnology
Choose an application
Viruses are microscopic agents that exist worldwide and are present in humans, animals, plants, and other living organisms in which they can cause devastating diseases. However, the advances of biotechnology and next-generation sequencing technologies have accelerated novel virus discovery, identification, sequencing, and manipulation, showing that they present unique characteristics that place them as valuable tools for a wide variety of biotechnological applications. Many applications of viruses have been used for agricultural purposes, namely concerning plant breeding and plant protection. Nevertheless, it is interesting to mention that plants have also many advantages to be used in vaccine production, such as the low cost and low risks they entail, showing once more the versatility of the use of viruses in biotechnology. Although it will obviously never be ignored that viruses are responsible for devastating diseases, it is clear that the more they are studied, the more possibilities they offer to us. They are now on the front line of the most revolutionizing techniques in several fields, providing advances that would not be possible without their existence. In this book there are presented studies that demonstrate the work developed using viruses in biotechnology. These studies were brought by experts that focus on the development and applications of many viruses in several fields, such as agriculture, the pharmaceutical industry, and medicine.
Bacteriophage --- Salmonella --- biocontrol --- comparative genomics --- phage diversity --- grapevine --- apple latent spherical virus vector --- virus-induced flowering --- reduced generation time --- breeding of grapevine --- virus elimination --- Newcastle disease virus --- reverse genetics --- vaccines --- infectious diseases --- cancer --- porcine epidemic diarrhea virus --- VLP --- chemokines --- pig --- vaccine --- SARS-CoV-2 --- COVID-19 --- phages --- CRISPR --- viruses --- prevention --- diagnosis --- treatment --- adeno-associated virus (AAV) vector --- jaagsiekte sheep retrovirus (JSRV) --- LTR --- enhancer --- transduction --- viral vaccines --- cancers --- COVID-19 vaccines --- self-replicating RNA vectors --- DNA-based vaccines --- RNA-based vaccines --- plant virus --- viroid --- viral vector --- virus-induced gene silencing (VIGS) --- CRISPR/Cas9 --- genome editing --- carotenoid biosynthesis --- circular RNA --- infectious bursal disease virus --- immunization --- recombinant Lactococcus lactis --- variant strain --- baculovirus --- insect cells --- bacmid --- Tn7 --- genome stability --- protein expression --- chikungunya virus --- VLPs --- bioreactor --- CRISPR/Cas systems --- viral vectors --- gene editing --- plant genome engineering --- viral resistance --- adeno-associated virus --- AAV --- cancer gene therapy --- prophage --- hydrothermal vent --- Hypnocyclicus thermotrophus --- lytic cassette --- Escherichia coli --- heterologous expression --- codon optimization --- codon harmonization --- expression vectors --- aspect ratio --- VNPs --- TMV --- PVX --- CPMV --- geminivirus --- theranostics --- CRISPR-cas9 --- clodronate --- macrophage --- gene therapy --- gene expression --- nanotechnology
Listing 1 - 9 of 9 |
Sort by
|